Companies / Abeona Therapeutics Inc. / Activity
Activity — Abeona Therapeutics Inc.
26 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | Seshadri Vishwas CEO | Sell | Common Stock | $372.3K | -70K -4.56% | 1,460,408 2.55% of shares | medium |
| Mar 31, 2026 | Seshadri Vishwas CEO | Sell | Common Stock | $131.5K | -30K -2.05% | 1,430,423 2.50% of shares | medium |
| Feb 2, 2026 | Silverstein Christine Berni Director | Sell | Common Stock | $102.2K | -20K -12.72% | 137,722 0.24% of shares | medium |
| Jan 22, 2026 | Vazzano Joseph Walter Executive | Sell | Common Stock | $99.5K | -19K -3.18% | 568,560 0.99% of shares | low |
| Feb 2, 2026 | Alland Leila Director | Sell | Common Stock | $92.0K | -18K -9.42% | 173,614 0.30% of shares | low |
| Feb 2, 2026 | Crombez Eric Director | Sell | Common Stock | $82.9K | -16K -20.42% | 63,456 0.11% of shares | low |
| Feb 2, 2026 | Wuchterl Donald A. Director | Sell | Common Stock | $75.4K | -15K -8.11% | 167,935 0.29% of shares | low |
| Jan 22, 2026 | O'Malley Brendan M. Executive | Sell | Common Stock | $72.4K | -14K -2.92% | 451,134 0.79% of shares | low |
| Jan 21, 2026 | Alvino Mark Director | Sell | Common Stock | $70.6K | -14K -21.69% | 48,752 0.09% of shares | low |
| Jan 22, 2026 | Vasanthavada Madhav Executive | Sell | Common Stock | $66.7K | -13K -3.81% | 318,619 0.56% of shares | low |
| May 22, 2026 | Alvino Mark Director | Sell | Common Stock | $35.5K | -7K -7.73% | 77,565 0.14% of shares | low |
| Feb 2, 2026 | Alvino Mark Director | Sell | Common Stock | $10.2K | -2K -2.32% | 84,065 0.15% of shares | low |
| Mar 16, 2026 | Vazzano Joseph Walter Executive | Sell | Common Stock | $3.7K | -785 -0.14% | 567,775 0.99% of shares | low |
| May 26, 2026 | Alvino Mark Director | Gift | Common Stock | $0 | -500 -0.64% | 77,065 0.13% of shares | low |
| Jan 20, 2026 | Vasanthavada Madhav Executive | Grant | Common Stock | $0 | +77K +30.09% | 331,229 0.58% of shares | low |
| Jan 26, 2026 | Zeiher Bernhardt G Director | Grant | Common Stock | $0 | +37K +79.15% | 84,458 0.15% of shares | low |
| Jan 20, 2026 | O'Malley Brendan M. Executive | Grant | Common Stock | $0 | +114K +32.49% | 464,712 0.81% of shares | low |
| Jan 20, 2026 | Seshadri Vishwas CEO | Grant | Common Stock | $0 | +365K +31.37% | 1,530,240 2.68% of shares | low |
| Jan 26, 2026 | Wuchterl Donald A. Director | Grant | Common Stock | $0 | +37K +25.66% | 182,749 0.32% of shares | low |
| Jan 26, 2026 | Charles Faith L. Director | Grant | Common Stock | $0 | +37K +26.83% | 176,407 0.31% of shares | low |
| Jan 26, 2026 | Amoroso Michael Director | Grant | Common Stock | $0 | +37K +20.68% | 217,779 0.38% of shares | low |
| Jan 26, 2026 | Alland Leila Director | Grant | Common Stock | $0 | +37K +24.17% | 191,679 0.34% of shares | low |
| Jan 26, 2026 | Silverstein Christine Berni Director | Grant | Common Stock | $0 | +37K +30.97% | 157,792 0.28% of shares | low |
| Jan 20, 2026 | Vazzano Joseph Walter Executive | Grant | Common Stock | $0 | +134K +29.45% | 587,226 1.03% of shares | low |
| Jan 26, 2026 | Crombez Eric Director | Grant | Common Stock | $0 | +37K +87.95% | 79,740 0.14% of shares | low |
| Jan 26, 2026 | Alvino Mark Director | Grant | Common Stock | $0 | +37K +76.54% | 86,065 0.15% of shares | low |